What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News A study on the behaviour of Covid-19 in nursing homes shows that some comorbidities and symptoms have a strong predictive value for mortality The research conducted by the Vall d'Hebron University Hospital in cooperation with the Catalan Association of Care Resources (ACRA) analyses the effects of Covid-19 in Catalan residential centres. News “Som de ciències”, el casal d’estiu per a fills i filles de professionals de Vall d’Hebron, apropa la ciència als infants en una edició centrada en els virus “Som de ciències”, el casal d’estiu per a fills i filles de professionals de Vall d’Hebron, apropa la ciència als infants en una edició centrada en els virus News New strategies to fight aggressive breast cancer CIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles. News IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID). News Six Vall d'Hebron research groups receive grants from the Strategic Plan for Research and Innovation in Health (PERIS) The projects will investigate issues such as stroke and endometrial cancer prevention. News A new model for studying metastasis enables faster and more affordable preliminary analysis A new strategy has been developed to identify genes, drugs, and cellular pathways that regulate the metastasis process using laboratory models. News The solidarity challenge to find a cure for GNB1 encephalopathy achieves its first goal raising more than €50,000 The micro-donation initiative is being carried out by Marc León, together with the relatives of the patients, for a research project in gene therapy headed by Dr. Miguel Chillón. News Dr. María José Soler, elected editor-in-chief of the Clinical Kidney Journal Dr. María José Soler, nephrologist at Vall d'Hebron and the VHIR, will become, in June 2022, the first editor-in-chief of the specialized journal Clinical Kidney Journal. News Vall d'Hebron participates in the largest study on non-rhabdomyosarcoma type paediatric soft tissue sarcomas The pediatric surgeon Gabriela Guillén is a co-author in this study of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) that lays the foundations for the treatment of this type of tumors. News Vall d'Hebron publishes four innovative works on different systemic diseases Articles from the Systemic Diseases research group at the VHIR focus on scleroderma, antiphospholipid syndrome, Sjögren's syndrome, and the relationship between cancer and inflammatory myopathy. News Ona Futura Foundation donates €40,000 for research on immune disorders related to pregnancy in Vall d’Hebron Ona Futura Foundation has signed a donation agreement with the Vall d'Hebron Research Institute (VHIR) to contribute to research on various immune disorders related to the pregnancy process. News Dr. Antoni Soriano, awarded by the European Society of Paediatric Infectious Diseases (ESPID) The VHIR researcher has been recognized for his research on the low transmissibility of COVID-19 from pediatric patients. News Vall d'Hebron leads a multicenter study that will assess a faster workflow for the management of patients with stroke The international multi-centric study WE-TRUST will assess the impact of the "Direct to Angiography" approach thanks to a computed tomography technology developed and improved by Philips. News Una nova calculadora per predir la mortalitat en pacients amb endocarditis infecciosa podria salvar vides L'eina està disponible online i permet ajudar a la presa de decisions mèdiques en pacients amb endocarditis infecciosa sotmesos a cirurgia cardíaca, una operació d'alt risc. News A new project seeks to extend nucleoside therapy to different mitochondrial disorders CIBERER and CIBEREHD will study the possible extension of therapy based on the administration of deoxyribonucleosides to other disorders characterized by problems in the replication of mitochondrial DNA. News Vall d'Hebron advances in the knowledge of the biological causes of Dent's disease The CIBBIM-Nanomedicine-Renal Pathophysiology group of the VHIR has developed renal cell models to investigate the pathophysiological mechanisms and help provide new drugs for the treatment of this disease. News Vall d’Hebron, UAB and UPC design an app to help assess the severity of symptoms in chronic fatigue syndrome Researchers have shown that heart rate variability is related to the severity of fatigue in women with chronic fatigue syndrome / myalgic encephalomyelitis. News Vall d’Hebron participa en la creació d’un nou sistema per identificar nòduls indicadors de possibles càncers pulmonars amb Intel·ligència Artificial Aquesta eina ha estat desenvolupada per Eurecat amb la col.laboració del Campus Vall d'Hebron coordinada pel Servei de Diagnòstic per la Imatge de l'Hospital, en el marc del projecte Deep Lung. News Mutua Madrileña Foundation grants two Vall d'Hebron projects Dr. Javier Torres and Dr. Alberto Sandiumenge lead the selected works in the field of rare diseases and transplantation. News Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards Vall d’Hebron University Hospital hosted the Catalan Institute of Health's (ICS) Research Conference earlier today, where the 2020 and 2021 ICS Research Awards were presented. Pagination First page « Previous page ‹ … Page 53 Page 54 Current page 55 Page 56 Page 57 … Next page › Last page »
